These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19320733)

  • 21. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
    Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
    Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population.
    Córdoba-Lanús E; Hernández-Jiménez JG; Medina-Coello C; Espinoza-Jiménez A; González A; Rodríguez-Pérez MD; Carretero-Hernández G; Almeida P; Suárez-Hernández J; Perera-Molinero A; Fernández-de-Misa R
    Arch Dermatol Res; 2014 Jan; 306(1):51-8. PubMed ID: 24170137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of MMP8 gene variation with an increased risk of malignant melanoma.
    Dębniak T; Jakubowska A; Serrano-Fernández P; Kurzawski G; Cybulski C; Chauhan SR; Laxton RC; Maleszka R; Lubinski J; Ye S
    Melanoma Res; 2011 Oct; 21(5):464-8. PubMed ID: 21642878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma risk associated with MC1R gene variants in Latvia and the functional analysis of rare variants.
    Ozola A; Azarjana K; Doniņa S; Proboka G; Mandrika I; Petrovska R; Cēma I; Heisele O; Eņģele L; Streinerte B; Pjanova D
    Cancer Genet; 2013 Mar; 206(3):81-91. PubMed ID: 23522749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variation at KIT locus may predispose to melanoma.
    Bourillon A; Hu HH; Hetet G; Lacapere JJ; André J; Descamps V; Basset-Seguin N; Ogbah Z; Puig S; Saiag P; Bagot M; Bensussan A; Grandchamp B; Dumaz N; Soufir N
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):88-96. PubMed ID: 23020152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms of GSTM1 and GSTT1, sun exposure and the risk of melanoma: a case-control study.
    Fortes C; Mastroeni S; Boffetta P; Innocenzi L; Antonelli G; Giovinazzo R; Anzidei P; Melchi F; D' Atri S; Pasquini P; Venanzetti F
    Acta Derm Venereol; 2011 May; 91(3):284-9. PubMed ID: 21461548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk associations of melanoma in a Southern European population: results of a case/control study.
    Nikolaou VA; Sypsa V; Stefanaki I; Gogas H; Papadopoulos O; Polydorou D; Plaka M; Tsoutsos D; Dimou A; Mourtzoukou E; Korfitis V; Hatziolou E; Antoniou C; Hatzakis A; Katsambas A; Stratigos AJ
    Cancer Causes Control; 2008 Sep; 19(7):671-9. PubMed ID: 18307049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline melanoma susceptibility and prognostic genes: a review of the literature.
    Ward KA; Lazovich D; Hordinsky MK
    J Am Acad Dermatol; 2012 Nov; 67(5):1055-67. PubMed ID: 22583682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
    Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
    Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No Evidence for BRAF as a melanoma/nevus susceptibility gene.
    Jackson S; Harland M; Turner F; Taylor C; Chambers PA; Randerson-Moor J; Swerdlow AJ; dos Santos Silva I; Beswick S; Bishop DT; Newton Bishop JA
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):913-8. PubMed ID: 15824163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis.
    Li C; Hu Z; Liu Z; Wang LE; Strom SS; Gershenwald JE; Lee JE; Ross MI; Mansfield PF; Cormier JN; Prieto VG; Duvic M; Grimm EA; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2526-32. PubMed ID: 17164380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
    Duffy DL; Box NF; Chen W; Palmer JS; Montgomery GW; James MR; Hayward NK; Martin NG; Sturm RA
    Hum Mol Genet; 2004 Feb; 13(4):447-61. PubMed ID: 14709592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer.
    Winsey SL; Haldar NA; Marsh HP; Bunce M; Marshall SE; Harris AL; Wojnarowska F; Welsh KI
    Cancer Res; 2000 Oct; 60(20):5612-6. PubMed ID: 11059748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients.
    Figl A; Scherer D; Nagore E; Bermejo JL; Dickes E; Thirumaran RK; Gast A; Hemminki K; Kumar R; Schadendorf D
    Mutat Res; 2009 Feb; 661(1-2):78-84. PubMed ID: 19073198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma.
    Gudbjartsson DF; Sulem P; Stacey SN; Goldstein AM; Rafnar T; Sigurgeirsson B; Benediktsdottir KR; Thorisdottir K; Ragnarsson R; Sveinsdottir SG; Magnusson V; Lindblom A; Kostulas K; Botella-Estrada R; Soriano V; Juberías P; Grasa M; Saez B; Andres R; Scherer D; Rudnai P; Gurzau E; Koppova K; Kiemeney LA; Jakobsdottir M; Steinberg S; Helgason A; Gretarsdottir S; Tucker MA; Mayordomo JI; Nagore E; Kumar R; Hansson J; Olafsson JH; Gulcher J; Kong A; Thorsteinsdottir U; Stefansson K
    Nat Genet; 2008 Jul; 40(7):886-91. PubMed ID: 18488027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma.
    Broberg K; Höglund M; Gustafsson C; Björk J; Ingvar C; Albin M; Olsson H
    Cancer Lett; 2007 Dec; 258(1):38-44. PubMed ID: 17900800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of polymorphic sites in the OCA2 gene with eye colour using the tree scanning method.
    Branicki W; Brudnik U; Kupiec T; Wolańska-Nowak P; Szczerbińska A; Wojas-Pelc A
    Ann Hum Genet; 2008 Mar; 72(Pt 2):184-92. PubMed ID: 18093281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
    Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
    Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.